StockNews.com Begins Coverage on Calithera Biosciences (NASDAQ:CALA)

Research analysts at StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research report issued to clients and investors on Monday. The brokerage set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Trading Up 354.5 %

NASDAQ:CALA opened at $0.01 on Monday. Calithera Biosciences has a twelve month low of $0.00 and a twelve month high of $0.12.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.